Skip to main content
logo
Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
100.61
+2.31 (2.35%)
At close: Sep 10, 2026, 4:00 PM EDT
101.00
+0.39 (0.39%)
After-hours: Sep 10, 2026, 7:30 PM EDT

Mirum Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-860.21-23.36-87.94-163.42-135.67-83.99
Depreciation & Amortization
25.9524.2423.6310.833.240.6
Other Amortization
1.991.741.661.12--
Loss (Gain) From Sale of Assets
------108
Loss (Gain) From Sale of Investments
------0.14
Stock-Based Compensation
103.9371.4248.4435.0227.0123.09
Other Operating Activities
440.941.51.9464.726.3318.7
Change in Accounts Receivable
-48.78-48.06-11.43-43.97-20.73-
Change in Inventory
-4.97-8.45-3.17-0.97-3.45-0.5
Change in Accounts Payable
65.9750.140.3130.787.6422.66
Change in Other Net Operating Assets
47.92-13.32-3.13-5.05-4.51-5.18
Operating Cash Flow
-227.2755.8310.33-70.94-120.14-132.76
Operating Cash Flow Growth
-440.70%----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1.47-0.95-0.99-0.11-0.28-0.02
Cash Acquisitions
----212.76--
Sale (Purchase) of Intangibles
-35--20-20--19
Investment in Securities
-136.31-23-69.13125.677.98-40.43
Other Investing Activities
-----108
Investing Cash Flow
-172.78-23.95-90.13-107.27.748.55

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
---305.3--
Total Debt Issued
672.44--305.3--
Net Debt Issued (Repaid)
672.44--305.3--
Issuance of Common Stock
308.5440.1417.7227.15114.649.01
Other Financing Activities
----195.86-5.5564.45
Financing Cash Flow
506.6140.1417.7336.6109.0973.47

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-2.73.22-1.3-0.130.01-0
Net Cash Flow
103.8675.24-63.4158.32-3.34-10.75

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-228.7454.879.33-71.05-120.41-132.78
Free Cash Flow Growth
-488.01%----
Free Cash Flow Margin
-37.01%10.53%2.77%-38.12%-156.26%-693.81%
Free Cash Flow Per Share
-4.081.090.20-1.74-3.54-4.38
Levered Free Cash Flow
76.6298.5616.67-91.35-68.57-96.18
Unlevered Free Cash Flow
83.03105.8123.95-83.03-58.59-85.19

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
13.0312.6512.656.82--
Cash Income Tax Paid
1.642.1610.13--
Change in Working Capital
60.14-19.7222.59-19.22-21.0516.98
SEC Filings: 10-K · 10-Q